DalsnaFinance › IPOs › Braveheart Bio › IPO
Braveheart Bio, Inc. completed its initial public offering on Nasdaq on August 3, 2026.
| Ticker | BRVE |
|---|---|
| Exchange | Nasdaq |
| Status | Completed |
| Listing date | August 3, 2026 |
| Sector | Pharmaceutical Preparations |
Braveheart Bio, Inc. listed on Nasdaq on 2026-08-03.
Ingested from SEC EDGAR (424B4, 8-A12B), CIK 2131524.
Braveheart Bio, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Braveheart Bio, Inc.. This page is general information, not investment advice.